temoporfin: Clinical Trials

5 trials of temoporfin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 unknown, 1 completed, 1 terminated. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 3, Completed 1, Terminated 1

Follow temoporfin: new trials by email Literature Review of temoporfin trials Research Report on temoporfin

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Tumoricidal Effect of Low Dose Foscan PDT in Patients With Inoperable Bile Duct Cancers
Temoporfin - Cholangiocarcinoma, Tumor
Phase 2CompletedChinese University of Hong Kong102014-03-282023-08-22
Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers
Temoporfin, Medical diode laser emitting light at a wavelength of 652 nm. (Ceralas PDT 652, CeramOptec GmbH) - Squamous Cell Carcinoma of the Head and Neck
Phase 2TerminatedUniversity of Arkansas12010-11-012012-12-03
FoscanĀ®-Mediated Photodynamic Therapy Versus Brachytherapy in Patients With Nasopharyngeal Carcinoma
FOSCAN - Nasopharyngeal Carcinoma
Phase 2UnknownMinistry of Health, Malaysia662009-01-012011-07-08
Single-arm Study of Photodynamic Laser Therapy Using Foscan for Non-curatively-resectable Bile Duct Carcinoma
Temoporfin - Non-curative Resectable Bile Duct Carcinoma
Phase 2UnknownUniversity of Salzburg352006-01-012009-11-18
Photodynamic Therapy in Treating Patients With Recurrent, Refractory, or Second Primary Head and Neck Cancer That Cannot Be Treated With Surgery or Radiation Therapy
temoporfin - Head and Neck Cancer
Phase 2UnknownQuintiles, Inc.751998-10-012013-12-19

Conditions studied

Head and Neck Neoplasms (2)  ·  Squamous Cell Carcinoma of Head and Neck (2)  ·  Carcinoma, Squamous Cell (1)  ·  Cholangiocarcinoma (1)  ·  Klatskin Tumor (1)  ·  Nasopharyngeal Carcinoma (1)  ·  Neoplasms (1)  ·  Recurrence (1)  ·  Salivary Gland Neoplasms (1)

Sponsors

Chinese University of Hong Kong (1)  ·  Ministry of Health, Malaysia (1)  ·  Quintiles, Inc. (1)  ·  University of Arkansas (1)  ·  University of Salzburg (1)

Countries

United States (2)  ·  Austria (1)  ·  Germany (1)  ·  Hong Kong (1)  ·  Malaysia (1)

Top investigators

Barbara Larson (1)  ·  Frieder Berr, Prof., MD (1)  ·  Lohse A, Prof., MD (1)  ·  Yoke Yeow Yap, MD (1)